| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/16/2004 | CA2528156A1 Staurosporine derivatives for hypereosinophilic syndrome |
| 12/16/2004 | CA2527793A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2527788A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| 12/16/2004 | CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 12/16/2004 | CA2527711A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 12/16/2004 | CA2527573A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
| 12/16/2004 | CA2527334A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists |
| 12/15/2004 | EP1486497A1 Novel pyridone derivative |
| 12/15/2004 | EP1486494A1 N-substituted benzothiophenesulfonamide derivative |
| 12/15/2004 | EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 12/15/2004 | EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/15/2004 | EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 12/15/2004 | EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| 12/15/2004 | EP1485379A1 Beta 3-adrenergic receptor agonists |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485360A2 Sodium channel blockers |
| 12/15/2004 | EP1485359A2 Sodium channel blockers |
| 12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485188A1 Portable oxygen concentrator |
| 12/15/2004 | EP1485121A2 Activated protein c formulations |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485085A1 Phosphate prodrugs of fluorooxindoles |
| 12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/15/2004 | EP1430033A4 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 12/15/2004 | EP1414468B1 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders |
| 12/15/2004 | EP1399155A4 Small molecules useful in the treatment of inflammatory disease |
| 12/15/2004 | EP1322301B1 Combination particles for the treatment of asthma |
| 12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
| 12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/15/2004 | EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections |
| 12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
| 12/15/2004 | CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 12/15/2004 | CN1555375A Compounds for inhibiting the release of inflammatory cytokines |
| 12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
| 12/15/2004 | CN1555359A Alkyl urea vitamin A protagonist i |
| 12/15/2004 | CN1555358A CCR-3 receptor antagonists v |
| 12/15/2004 | CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii |
| 12/15/2004 | CN1555356A Bisphenol derivative as NHE-3 inhibitor |
| 12/15/2004 | CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations |
| 12/15/2004 | CN1555266A Hormone replacement therapy |
| 12/15/2004 | CN1555263A Compositions for treatment of common cold |
| 12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
| 12/15/2004 | CN1554433A Method for preparing Qingkailing freezo dried powder injection for injection |
| 12/15/2004 | CN1554411A Rhinitis liquid and its preparing method |
| 12/15/2004 | CN1554407A Medicine for clearing away lung-heat, eliminating phaegn, reliveing cough and asthma and its preparing method |
| 12/15/2004 | CN1554388A Drink capable of treating rhinitis |
| 12/15/2004 | CN1554387A Medicine for treating acute and chronic tonsillitis |
| 12/15/2004 | CN1554378A Medicinal paste for treating laryngopharyngitis, tonsillitis and infantile parotitis |
| 12/15/2004 | CN1554367A Medicine for treating upper respiratory tract infection |
| 12/15/2004 | CN1554338A Sodium bisulfite andrographolide freeze drying preparation and its preparing method |
| 12/15/2004 | CN1179970C Purine derivatives |
| 12/15/2004 | CN1179961C Sulfonamides for treatment of endothelin-mediated disorders |
| 12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/15/2004 | CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 12/15/2004 | CN1179726C Application of naringin in preapring medicine for supporting treatment of SARS |
| 12/15/2004 | CN1179723C Application of geldanamycin in preparation of medicine for curing SARS |
| 12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
| 12/14/2004 | US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
| 12/09/2004 | WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 12/09/2004 | WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 12/09/2004 | WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use |
| 12/09/2004 | WO2004106317A1 Benzofuran compound and medicinal composition containing the same |
| 12/09/2004 | WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof |
| 12/09/2004 | WO2004106305A1 New p2x7 receptor antagonists and their use |
| 12/09/2004 | WO2004106302A1 Novel substituted 3-sulfur indoles |
| 12/09/2004 | WO2004106279A2 CRYSTALLINE FORM OF β2 ADRENERGIC RECEPTOR AGONIST |
| 12/09/2004 | WO2004105793A2 Soluble clca-1 and antagonists to clca-1 |
| 12/09/2004 | WO2004105760A1 Use of efletirizine for treating persistent allergic rhinitis |
| 12/09/2004 | WO2004105731A1 Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea |
| 12/09/2004 | WO2004105726A1 Novel lipid mixtures for synthetic surfactants |
| 12/09/2004 | WO2004089892A3 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/09/2004 | WO2004083851A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| 12/09/2004 | WO2004060262A3 Modulators of notch signalling for use in immunotherpapy |
| 12/09/2004 | WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
| 12/09/2004 | US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders |
| 12/09/2004 | US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors |
| 12/09/2004 | US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248985 N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; salt formation, crystallization |
| 12/09/2004 | US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide |
| 12/09/2004 | US20040248953 3-Arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/09/2004 | US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors |